Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
Open accessAbstract
Aim We analysed the impact of tobacco smoking over several healthy lifestyle habits along with the impact on 10-years cardiovascular event (CVE) risk in the CLAMORS schizophrenia cohort. Methods This analysis was performed within the scope of the CLAMORS study which included consecutive outpatients meeting DSM-IV criteria for schizophrenia spectrum disorder. Beside smoking history, data on usual healthy lifestyle habits included current exercise, saturated fat sparing diet, low-caloric diet, and daily dietary fibre, salt, caffeine and alcohol consumption were recorded. The 10-year CVE risk was calculated with Framingham function. Results 1704 patients (61.1% male), 18 to 74 years were examined. Prevalence of smoking was 54.54% (95% CI: 52.16%-56.90%) significantly higher than in age and sex matched general population subjects, 31.51% (31.49%-31.52%); OR=2.61 (2.37-2.87, p<0.0001). After controlling by confounders smokers showed a 10-year CVE risk excess versus non-smokers of 2.63 (2.16-3.09), p<0.001. Smoking cessation would reduce the likely of high/very high 10-year CVE risk (above 10%) by near 90% [OR=0.10 (0.06-0.18), p<0.0001]. Also, smokers were more likely to consume alcohol daily [4.13 (3.07-5.54), p<0.0001] and caffeine [3.39 (2.72-4.23), p<0.0001] than non-smoker patients with schizophrenia, and less likely to avoid daily consumption of salt [0.58 (0.43-0.78), p<0.0001], saturated fat [0.71 (0.56-0.91), p=0.006], high fibre diet [0.67 (0.53-0.84), p=0.001], or to follow a low-caloric diet [0.63 (0.48-0.81), p<0.0001]. Smokers also were less likely to do exercise habitually [0.62 (0.48-0.82, p=0.001]. Conclusion Compared with the general population, patients with schizophrenia showed significant higher prevalence of smoking. Smokers who stop smoking would benefit by a near 90% reduction in the likely of 10-year cardiovascular event risk above 10%.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A large study from Spain found that 55% of nearly 2,000 outpatients with schizophrenia were smokers.
“A large study from Spain found that 55% of nearly 2,000 outpatients with schizophrenia were smokers (Bobes et al. 2010).”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Bobes et al. 2010
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · see citing works
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554 · see citing works
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276 · see citing works
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087 · see citing works
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · see citing works
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951 · see citing works
Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia
Sernyak, M. J., LESLIE, D. L., Alarcón, R. D., LOSONCZY, M. F., & Rosenheck, R. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.561 · Cited by 623 · see citing works
Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus
Yeh, H. C., Duncan, B. B., Schmidt, M. I., Wang, N.-Y., & Brancati, F. L. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-1-201001050-00005 · Cited by 360 · see citing works
Hiroeh, U., Appleby, L., Mortensen, P. B., & Dunn, G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07216-6 · Cited by 327 · see citing works
Cohn, T. A., Prud’homme, D., Streiner, D. L., Kameh, H., & Remington, G. J. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901106 · Cited by 290 · see citing works
Serious Cardiovascular Events and Mortality Among Patients with Schizophrenia
Enger, C. L., Weatherby, L. B., Reynolds, R. F., Glasser, D. B., & Walker, A. M. (2003) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000105996.62105.07 · Cited by 215 · see citing works
Bobes, J., Arango, C., Aranda, P., Carmena, R., García-García, M., & Rejas, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.09.025 · Cited by 195 · see citing works
Self-citationOsborn, D., Nazareth, I., & King, M. (2007) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-007-0247-3 · Cited by 193 · see citing works
Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing, D. A. (2004) · PubMed · Cited by 169 · see citing works
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia
Barnett, A. H., Mackin, P., Chaudhry, I. B., Farooqi, A. M., Gadsby, R., Heald, A. H., Hill, J., Millar, H. L., Peveler, R., Rees, A., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107075509 · Cited by 166 · see citing works
Schizophrenia and physical health problems
Von Hausswolff‐Juhlin, Y., Bjartveit, M., Lindström, E., & Jones, P. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01309.x · Cited by 161 · see citing works
Cigarette smoking and mortality risk in people with schizophrenia
Kelly, D. L., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Boggs, D. L., Warren, K. R., Feldman, S., Shim, J.-C., Love, R. C., et al. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp152 · Cited by 158 · see citing works
Prevalence of smoking in psychiatric patients
Poirier, M.-F., Canceil, O., Baylé, F., Millet, B., Bourdel, M.-C., Moatti, C., Olié, J.-P., & Attar-Lévy, D. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00304-9 · Cited by 150 · see citing works
A 4-Fold Risk of Metabolic Syndrome in Patients With Schizophrenia
Saari, K. M., Lindeman, S. M., Viilo, K. M., Isohanni, M. K., Järvelin, M., Laurén, L., Savolainen, M. J., & Koponen, H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0503 · Cited by 146 · see citing works
Smoking and Vulnerability for Schizophrenia
de León, J. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.405 · Cited by 143 · see citing works
Bobes, J., Rejas, J., García-García, M., Rico‐Villademoros, F., García‐Portilla, M. P., Fernández, I., & Hernández, G. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00431-0 · Cited by 140 · see citing works
Self-citationTobacco Smoking and Bipolar Disorder
González-Pinto, A. M., Gutiérrez, M., Ezcurra, J., Aizpuru, F., Mosquera, F., López‐Mahía, P., & de León, J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0503 · Cited by 133 · see citing works
Diagnosis, epidemiology and pathogenesis of diabetes mellitus: An update for psychiatrists
Holt, R. I. G. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.47.s55 · Cited by 107 · see citing works
Nicotine dependence and symptoms in schizophrenia
Aguilar, M., Gurpegui, M., Diaz, F., & de Leon, J. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.3.215 · Cited by 105 · see citing works
Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment
Barr, A. M., Procyshyn, R. M., Hui, P., Johnson, J. L., & Honer, W. G. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.027 · Cited by 85 · see citing works
Citation Bias in Reported Smoking Prevalence in People with Schizophrenia
Chapman, S., Ragg, M., & McGeechan, K. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802653372 · Cited by 83 · see citing works
A clinical study of the association of antipsychotics with hyperlipidemia
de León, J., Susce, M. T., Johnson, M., Hardin, M., Pointer, L., Ruaño, G., Windemuth, A., & DÍAZ, F. J. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.015 · Cited by 76 · see citing works
Lamberti, J. S., Crilly, J. F., Maharaj, K., Olson, D. P., Wiener, K., Dvorin, S., Costea, G. O., Bushey, M. P., & Dietz, M. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0517 · Cited by 74 · see citing works
Tabac et schizophrénie : aspects épidémiologiques et cliniques
Dervaux, A., & Laqueille, X. (2008) · L Encéphale · doi:10.1016/j.encep.2007.04.003 · Cited by 63 · see citing works
Impact of substance use on the physical health of patients with bipolar disorder
García‐Portilla, M. P., Sáiz, P. A., Benabarre, A., Flórez, G., Bobes-Bascarán, T., Díaz, E. M. F., Bousoño, M., & Bobes, J. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01498.x · Cited by 47 · see citing works
Self-citationde León, J., Susce, M. T., DÍAZ, F. J., Rendon, D. M., & Velásquez, D. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1112 · Cited by 43 · see citing works
Baker, A., RICHMOND, R. L., Castle, D. J., Kulkarni, J., KAY‐LAMBKIN, F. J., Sakrouge, R., Filia, S., & Lewin, T. J. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802607147 · Cited by 39 · see citing works
Heart Disease, Schizophrenia, and Affective Psychoses: Epidemiology of Risk in Primary Care
McDermott, S. W., Moran, R., Platt, T., Isaac, T., Wood, H., & Dasari, S. (2005) · Community Mental Health Journal · doi:10.1007/s10597-005-6431-6 · Cited by 39 · see citing works
Hyperglycemia and Hypertriglyceridemia in Real World Patients on Antipsychotic Therapy
Gupta, S., Steinmeyer, C. H., Frank, B. L., Madhusoodanan, S., Lockwood, K., Lentz, B., & Keller, P. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200309000-00007 · Cited by 39 · see citing works
Morgan, M. G., Scully, P. J., Youssef, H. A., Kinsella, A., Owens, J. M., & Waddington, J. L. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00002-7 · Cited by 34 · see citing works
Smoking Cessation in Patients With Psychiatric Disorders
Gelenberg, A. J., de León, J., Evins, A. E., Parks, J., & Rigotti, N. A. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0109 · Cited by 26 · see citing works
Kirkpatrick, B. W. (2009) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/s2173-5050(09)70040-8 · Cited by 24 · see citing works
Kirkpatrick, B. W. (2009) · Revista de Psiquiatría y Salud Mental · doi:10.1016/s1888-9891(09)72400-0 · Cited by 17 · see citing works
Cardiovascular disease in relation to weight in deceased persons with schizophrenia
Conley, R. R., Shim, J.-C., Kelly, D. L., Feldman, S. M., Yu, Y. W., & McMahon, R. P. (2005) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2005.03.007 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & Binder, M. D. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,087 · see citing works
Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913 · see citing works
DE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870 · see citing works
Self-citationNordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778 · see citing works
Bickel, W. K., Jarmolowicz, D. P., Mueller, E. T., Koffarnus, M. N., & Gatchalian, K. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.02.004 · Cited by 604 · see citing works
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
Kennedy, J. L., Altar, C. A., Taylor, D. L., Degtiar, I., & Hornberger, J. C. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32836508e6 · Cited by 392 · see citing works
The dietary pattern of patients with schizophrenia: A systematic review
Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P. K., & Mondelli, V. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.005 · Cited by 399 · see citing works
Mitchell, A. J., Vancampfort, D., Herdt, A. D., Yu, W., & Hert, M. D. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs082 · Cited by 331 · see citing works
A systematic review of correlates of physical activity in patients with schizophrenia
Vancampfort, D., Knapen, J., Probst, M., Scheewe, T., Remans, S., & De Hert, M. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01814.x · Cited by 306 · see citing works
Dietary intake of people with severe mental illness: systematic review and meta-analysis
Teasdale, S. B., Ward, P. B., Samaras, K., Firth, J., Stubbs, B., Tripodi, E., & Burrows, T. L. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.20 · Cited by 302 · see citing works
Henderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M., & Copeland, P. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00115-7 · Cited by 288 · see citing works
Morgan, V. A., McGrath, J. J., Jablensky, A. V., Badcock, J. C., Waterreus, A. J., Bush, R. A. B., Carr, V. J., Castle, D. J., Cohen, M. A., Galletly, C. A., et al. (2013) · Psychological Medicine · doi:10.1017/s0033291713002973 · Cited by 192 · see citing works
Vancampfort, D., Probst, M., Scheewe, T., De Herdt, A., Sweers, K., Knapen, J., van Winkel, R., & De Hert, M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.026 · Cited by 173 · see citing works
Tobacco Use Before, At, and After First-Episode Psychosis: A Systematic Meta-Analysis
Myles, N., Newall, H. D., Curtis, J., Nielssen, O., Shiers, D., & Large, M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07222 · Cited by 158 · see citing works
Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia
Vancampfort, D., Probst, M., Knapen, J., Carraro, A., & De Hert, M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.046 · Cited by 149 · see citing works
Rüther, T., Bobes, J., De Hert, M., Svensson, T. H., Mann, K., Batra, A., Gorwood, P., & Möller, H. J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.11.002 · Cited by 149 · see citing works
Self-citationWearne, T. A., & Cornish, J. L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00491 · Cited by 144 · see citing works
Vancampfort, D., Probst, M., Sweers, K., Maurissen, K., Knapen, J., & Hert, M. A. F. D. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01666.x · Cited by 139 · see citing works
Vancampfort, D., De Hert, M., Skjerven, L. H., Gyllensten, A. L., Parker, A., Mulders, N., Nyboe, L., Spencer, F., & Probst, M. (2012) · Disability and Rehabilitation · doi:10.3109/09638288.2011.587090 · Cited by 127 · see citing works
Soundy, A., Roskell, C., Stubbs, B., & Vancampfort, D. (2014) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2013.12.002 · Cited by 131 · see citing works
Crockford, D. N., & Addington, D. E. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717720196 · Cited by 113 · see citing works
Suvisaari, J., Keinänen, J., Eskelinen, S., & Mantere, O. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0704-4 · Cited by 123 · see citing works
Moreno, C., Nuevo, R., Chatterji, S., Verdes, E., Arango, C., & Ayuso‐Mateos, J. L. (2013) · World Psychiatry · doi:10.1002/wps.20070 · Cited by 108 · see citing works
Self-citationMitchell, A. J., Vancampfort, D., Binder, M. D., & Stubbs, B. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.11.006 · Cited by 96 · see citing works
Jakobsen, A. S., Speyer, H., Nørgaard, H. C. B., Karlsen, M., Hjorthøj, C. R., Krogh, J., Mors, O. N., Nordentoft, M., & Toft, U. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.03.016 · Cited by 92 · see citing works
Vancampfort, D., Probst, M., Scheewe, T. W., Knapen, J., Herdt, A. D., & Hert, M. A. F. D. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01825.x · Cited by 80 · see citing works
Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Yuen, J. W. Y., Kim, D. D., Procyshyn, R. M., White, R. F., Honer, W. G., & Barr, A. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00203 · Cited by 79 · see citing works
A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia
Nurjono, M., Lee, J., & Chong, S. A. (2012) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2012.10.2.61 · Cited by 75 · see citing works
Cardiovascular aspects of antipsychotics
Raedler, T. J. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833f46c9 · Cited by 89 · see citing works
Godin, O., Leboyer, M., Gaman, A., Aouizerate, B., Berna, F. S., Brunel, L., Capdevielle, D., Chéreau, I., Dorey, J., Dubertret, C., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.047 · Cited by 68 · see citing works
Vancampfort, D., Sweers, K., Probst, M., Maurissen, K., Knapen, J., Minguet, P., & Hert, M. A. F. D. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.12.007 · Cited by 65 · see citing works
Vancampfort, D., Probst, M., Sweers, K., Maurissen, K., Knapen, J., & Binder, M. D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.11.027 · Cited by 64 · see citing works
Disordered Eating among People with Schizophrenia Spectrum Disorders: A Systematic Review
Sankaranarayanan, A., Johnson, K., Mammen, S. J., Wilding, H., Vasani, D., Murali, V., Mitchison, D., Castle, D. J., & Hay, P. (2021) · Nutrients · doi:10.3390/nu13113820 · Cited by 60 · see citing works
Pachas, G. N., Cather, C., Pratt, S. I., Hoeppner, B. B., Nino, J., Carlini, S. V., Achtyes, E. D., Lando, H. A., Mueser, K. T., Rigotti, N. A., et al. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.663675 · Cited by 58 · see citing works
Chase, K. A., & Sharma, R. P. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001101 · Cited by 55 · see citing works
Nordentoft, M., Plana‐Ripoll, O., & Laursen, T. M. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000697 · Cited by 52 · see citing works
Prevalence of Metabolic Syndrome Among Patients with Schizophrenia in Singapore
Lee, J., Nurjono, M., Wong, A., & Salim, A. (2012) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v41n10p457 · Cited by 50 · see citing works
Correlates of physical activity in people living with psychotic illness
Suetani, S., Waterreus, A. J., Morgan, V. A., Foley, D. L., Galletly, C. A., Badcock, J. C., Watts, G. F., McKinnon, A. E., Castle, D. J., Saha, S., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12594 · Cited by 47 · see citing works
Wu, S., Chen, S., Liu, S., Sun, F., Juang, J. J., Lee, H., Kao, K., Dewey, M. E., Prince, M. J., & Stewart, R. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134763 · Cited by 45 · see citing works
Khatana, S. A. M., Kane, J., Taveira, T. H., Bauer, M. S., & Wu, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019298 · Cited by 42 · see citing works
Kraemer, S., Minarzyk, A., Forst, T. M., Kopf, D., & Hundemer, H. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-173 · Cited by 41 · see citing works
Ellingrod, V. L., Taylor, S. F., Brook, R. D., Evans, S. J., Zöllner, S. K., Grove, T. B., Gardner, K. M., Bly, M. J., Pop‐Busui, R., & Dalack, G. W. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.031 · Cited by 40 · see citing works
Dutra, S. J., Stoeckel, L. E., Carlini, S. V., Pizzagalli, D. A., & Evins, A. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2373-6 · Cited by 40 · see citing works
Lee, S., Park, M.-H., Patkar, A. A., & Pae, C. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.003 · Cited by 40 · see citing works
Lang, X., Liu, Q., Fang, H.-L., Zhou, Y., Forster, M. T., Li, Z., & Zhang, X. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05983-9 · Cited by 41 · see citing works
Tobacco smoking and nicotine dependence in first episode and established psychosis
Lally, J., Spaducci, G., Gardner-Sood, P., Atakan, Z., Greenwood, K., Forti, M. D., Ismail, K., Murphy, K. C., Smith, S. M., McNeill, A. D., et al. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.05.002 · Cited by 37 · see citing works
Zhou, Y., Song, X., Guo, Y., Lang, X., Li, Z., & Zhang, X. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.105061 · Cited by 35 · see citing works
Gaughran, F., Stahl, D. R., Ismail, K., Atakan, Z., Lally, J., Gardner-Sood, P., Patel, A. K., David, A. S., Hopkins, D., Harries, B., et al. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-263 · Cited by 34 · see citing works
Increased Framingham 10-year CVD risk in Chinese patients with schizophrenia
Tay, Y. H., Nurjono, M., & Lee, J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.03.023 · Cited by 34 · see citing works
Vancampfort, D., Probst, M., Sweers, K., Maurissen, K., Knapen, J., Willems, J. B., Heip, T., & Hert, M. A. F. D. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.01.009 · Cited by 34 · see citing works
CLINICAL EXOME SEQUENCING IN DEMENTIAS: A PRELIMINARY STUDY
Zalar, B., Maver, A., Kovanda, A., Peterlin, A., & Peterlin, B. (2018) · Psychiatria Danubina · doi:10.24869/psyd.2018.216 · Cited by 34 · see citing works
The Association between Lifestyle Choices and Schizophrenia Symptoms
Kalinowska, S., Trześniowska-Drukała, B., Kłoda, K., Safranow, K., Misiak, B., Cyran, A., & Samochowiec, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10010165 · Cited by 33 · see citing works
Martín-Sierra, A., Vancampfort, D., Probst, M., Bobes, J., Maurissen, K., Sweers, K., Schepper, E. D., & Hert, M. D. (2011) · PubMed · Cited by 32 · see citing works
Self-citationQuality of life and physical activity levels in outpatients with schizophrenia
Gomes, E., Bastos, T. C. L., Probst, M., et al. (2016) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2015-1709 · Cited by 32 · see citing works
Cigarette Smoking and Cardiovascular Disease: Lessons from Framingham
Filion, K. B., & Luepker, R. V. (2013) · Global Heart · doi:10.1016/j.gheart.2012.12.005 · Cited by 32 · see citing works
Management of Schizophrenia in Late Life with Antipsychotic Medications
Suzuki, T., Remington, G. J., Uchida, H., Rajji, T. K., Graff‐Guerrero, A., & Mamo, D. C. (2011) · Drugs & Aging · doi:10.2165/11595830-000000000-00000 · Cited by 31 · see citing works
Preventing breast cancer in women with schizophrenia
Seeman, M. V. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01626.x · Cited by 27 · see citing works
García‐Portilla, M. P., García-Álvarez, L., Sarramea, F., Galván, G., Díaz-Mesa, E., Bobes-Bascarán, T., Al‐Halabí, S., Elizagárate, E., García, C. I., Sáiz, P. A., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.011 · Cited by 28 · see citing works
Self-citationHahn, L. A., Rigby, A., & Galletly, C. A. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413491158 · Cited by 26 · see citing works
Vancampfort, D., Sweers, K., Probst, M., Mitchell, A. J., Knapen, J., & Binder, M. D. (2011) · Community Mental Health Journal · doi:10.1007/s10597-011-9431-8 · Cited by 26 · see citing works
Clinical characteristics of heavy and non-heavy smokers with schizophrenia
Wehring, H. J., Liu, F., McMahon, R. P., Mackowick, K. M., Love, R. C., Dixon, L. B., & Kelly, D. L. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.024 · Cited by 26 · see citing works
Reliability and validity of 6MWT for outpatients with schizophrenia: A preliminary study
Gomes, E., Bastos, T. C. L., Probst, M., Ribeiro, J. C., Silva, G., & Corredeira, R. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.066 · Cited by 25 · see citing works
Patient-Informed Treatment Development of Behavioral Smoking Cessation for People With Schizophrenia
Wilson, S. M., Thompson, A. C., Currence, E. D., Thomas, S. P., Dedert, E. A., Kirby, A. C., Elbogen, E. B., Moore, S. D., Calhoun, P. S., & Beckham, J. C. (2018) · Behavior Therapy · doi:10.1016/j.beth.2018.07.004 · Cited by 24 · see citing works
Mackin, P., Waton, T., Watkinson, H., & Gallagher, P. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2010.08.011 · Cited by 24 · see citing works
Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review
Saccaro, L. F., Aimo, A., Panichella, G., & Sentissi, O. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1343427 · Cited by 27 · see citing works
Semız, M., Yücel, H., Kavakçı, Ö., Yıldırım, O., Zorlu, A., Yılmaz, M. B., Küçükdurmaz, Z., & Canan, F. (2013) · Europe PMC (PubMed Central) · Cited by 23 · see citing works
Cigarette smoking in community-dwelling patients with schizophrenia in China
Hou, Y., Xiang, Y., Yan, F., Ungvari, G. S., Dickerson, F., Chiu, H. F. K., Lai, K. Y. C., Lee, E. H. M., Li, W.-Y., Li, W.-X., et al. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.07.011 · Cited by 22 · see citing works
Bobes, J., Alegría, A. A., Sáiz-González, M. D., Barber, I., Pérez, J. L., & Sáiz‐Ruiz, J. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2010.04.004 · Cited by 22 · see citing works
Self-citation10-year CVD risk in Han Chinese mainland patients with schizophrenia
Zhao, S., Xia, H., Mu, J., Wang, L., Zhu, L., Wang, A., & Zhou, X. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.020 · Cited by 22 · see citing works
Nurjono, M., Tay, Y. H., & Lee, J. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.024 · Cited by 21 · see citing works
Pawełczyk, T., Trafalska, E., Pawełczyk, A. M., & Kotlicka‐Antczak, M. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12267 · Cited by 20 · see citing works
Nover, C. H. (2013) · Social Work in Health Care · doi:10.1080/00981389.2013.797537 · Cited by 20 · see citing works
Lang, X., Zhou, Y., Zhao, L., Gu, Y., Wu, X. L., Zhao, Y., Li, Z., & Zhang, X. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105344 · Cited by 19 · see citing works
Nover, C. H., & Jackson, S. S. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-116 · Cited by 19 · see citing works
Li, Z., Wang, S., Chen, Y., Wu, X. L., Gu, Y., Lang, X., Wu, F., & Zhang, X. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab038 · Cited by 18 · see citing works
Paraoxonase 1 activity and lipid profile in schizophrenic patients
Mabrouk, H., Mechria, H., Mechri, A., et al. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.12.019 · Cited by 17 · see citing works
Costa, R., Teasdale, S. B., Abreu, S., Bastos, T. C. L., Probst, M., Rosenbaum, S., Ward, P. B., & Corredeira, R. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1642426 · Cited by 17 · see citing works
Health-related quality of life and metabolic risk in patients with psychosis
Foldemo, A., Wärdig, R. E., Bachrach‐Lindström, M., Edman, G., Holmberg, T., Lindström, T., Valter, L., & Ösby, U. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.029 · Cited by 16 · see citing works
Metabolic Syndrome: Differences between Psychiatric and Internal Medicine Patients
Margari, F., Zagaria, G., Lozupone, M., Minerva, F., Pisani, R., Palasciano, G., Pastore, A., Palmieri, V. O., & Todarello, O. (2013) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.45.3.a · Cited by 16 · see citing works
Lally, J., Loughlin, A. O., Stubbs, B., Guérandel, A., O'Shea, D. B., & Gaughran, F. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1445968 · Cited by 17 · see citing works
Derivation of poly-methylomic profile scores for schizophrenia
Watkeys, O. J., Cohen‐Woods, S., Quidé, Y., Cairns, M. J., Overs, B. J., Fullerton, J. M., & Green, M. J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109925 · Cited by 16 · see citing works
Management of Cardiovascular Health in People with Severe Mental Disorders
Lemogne, C., Blacher, J., Airagnes, G., Hoertel, N., Czernichow, S., Danchin, N., Meneton, P., Limosin, F., & Fiedorowicz, J. G. (2021) · Current Cardiology Reports · doi:10.1007/s11886-020-01436-5 · Cited by 16 · see citing works
Medenblik, A. M., Mann, A. J., Beaver, T. A., Dedert, E. A., Wilson, S. M., Calhoun, P. S., & Beckham, J. C. (2020) · Journal of Dual Diagnosis · doi:10.1080/15504263.2020.1797259 · Cited by 16 · see citing works
Sediment transport in mountain rivers
Ancey, C., Bohorquez, P., & Bardou, E. (2014) · Cited by 15 · see citing works
Psychiatric Disorders - Worldwide Advances
Uehara, T. (2011) · InTech eBooks · doi:10.5772/1289 · Cited by 15 · see citing works
The Association between Dystemperament and Prevention of Diseases: A Systematic Review
kiani, S. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19023.8511 · Cited by 15 · see citing works
Bruins, J., Jörg, F., van den Heuvel, E. R., Bartels‐Velthuis, A. A., Corpeleijn, E., Muskiet, F. A. J., Pijnenborg, G. H. M., & Bruggeman, R. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.059 · Cited by 13 · see citing works
Rasmussen, M., Klinge, M., Krogh, J., Nordentoft, M., & Tønnesen, H. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021114 · Cited by 14 · see citing works
Zhang, X.-Y., Chen, D.-C., Tan, Y.-L., Xiu, M. H., Cui, J., Hui, L., Yang, F. D., & Kosten, T. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3239-x · Cited by 16 · see citing works
Sleep quality in patients with schizophrenia: The relevance of physical activity
Costa, R., Bastos, T. C. L., Probst, M., Seabra, A., Vilhena, E., & Corredeira, R. (2018) · Mental health and physical activity · doi:10.1016/j.mhpa.2018.04.004 · Cited by 14 · see citing works
Healthy lifestyle intervention for people with severe mental disorders
Baker, A., KAY‐LAMBKIN, F. J., RICHMOND, R. L., Filia, S., Castle, D. J., Williams, J. M., & Thornton, L. K. (2011) · Mental Health and Substance Use · doi:10.1080/17523281.2011.555086 · Cited by 14 · see citing works
George, S. E., & Buck, K. D. (2018) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.20180036 · Cited by 12 · see citing works
Programas de cesación tabáquica para personas con esquizofrenia: una necesidad urgente no cubierta
García‐Portilla, M. P., & Bobes, J. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2016.09.002 · Cited by 12 · see citing works
Self-citationWoldekidan, N. A., Mohammed, A. S., Degu, A., & Tadiwos, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256195 · Cited by 12 · see citing works
Lv, M., Wang, X., Wang, Z., Li, X., Wang, L., Tan, Y., & Zhang, X. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1164968 · Cited by 12 · see citing works
García‐Portilla, M. P., García-Álvarez, L., Sáiz, P. A., Díaz-Mesa, E., Galván, G., Sarramea, F., Garcia-Blanco, J., Elizagárate, E., & Bobes, J. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110100373 · Cited by 12 · see citing works
Self-citationDickerson, F., Yu, A., Dalcin, A., Jerome, G. J., Gennusa, J. V., Charleston, J. B., Crum, R. M., Campbell, L. M., Oefinger, M., Appel, L. J., et al. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.749829 · Cited by 11 · see citing works
Alonso, Y., Miralles, C., Algora, M. J., Valiente-Pallejà, A., Sánchez‐Gistau, V., Muntané, G., Labad, J., Vilella, E., & Martorell, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-15479-x · Cited by 10 · see citing works
Godin, O., Pignon, B., Szöke, A., Boyer, L., Aouizerate, B., Schorr, B., André, M., Capdevielle, D., Chéreau, I., Coulon, N., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110641 · Cited by 10 · see citing works
Metabolic syndrome among schizophrenia patients: Study from a rural community of south India
Kumar, C. N., Thirthalli, J., Suresha, K. K., Arunachala, U., & Gangadhar, B. N. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.06.013 · Cited by 10 · see citing works
- Authors
- Bobes, J., Arango, C., Garcia-Garcia, M., & Rejas, J.
- Affiliations
- Universidad de Oviedo (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Pfizer (Spain) (ES)
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 119
- Issue
- 1-3
- Pages
- 101-109
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2152889938
- Cited by
- 181
- References
- 40
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 6 · 2021: 15 · 2020: 6 · 2019: 8 · 2018: 20 · 2017: 8 · 2016: 12 · 2015: 9 · 2014: 12 · 2013: 20 · 2012: 19
- FWCI
- 14.93
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Consultation of the Doctoral Thesis Database (TESEO) (Ministerio de Educación, Cultura y Deporte) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- schizophrenia spectrum disorders, smoking
- MeSH terms
- Cardiac Rehabilitation, Adolescent, Adult, Aged, Cardiovascular Diseases, Cross-Sectional Studies, Feeding Behavior, Female, Health Status Indicators, Health Surveys, Humans, Life Style, Male, Middle Aged, Psychotic Disorders, Risk, Schizophrenia, Schizophrenic Psychology, Smoking, Spain, Cohort Studies, Comorbidity, Case-Control Studies, Smoking Cessation, Risk Assessment, Metabolic Syndrome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review